In addition, our results showed that the positive expression of PD-L1 was more common at the interface between the tumor and non-neoplastic tissues and was more frequently seen in patients with TNM stages I-II; thus, to some extent, the expression of PD-L1 indicated an effective immune response in the early stages of cancer progression. Here, CD274 is linked to cancer.